Design Therapeutics Inc.

NASDAQ: DSGN · Real-Time Price · USD
5.35
0.19 (3.68%)
At close: Aug 15, 2025, 3:59 PM
5.33
-0.37%
After-hours: Aug 15, 2025, 04:04 PM EDT

Design Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-19.08M -17.71M -13.65M -13.04M -11.79M -11.11M -11.84M -15.79M -19.94M -19.29M -17.34M -17.7M -15M -13.27M -11.06M -11.32M -7.64M -5.51M
Depreciation & Amortization
-1.82M 159K 149K -4.61M 151K 143K 138K 137K 133K 129K 124K 108K 92K 82K 82K 31K 12K 4K
Stock-Based Compensation
3.98M 3.54M 3.47M 3.12M 3.3M 3.18M 2.72M 3.22M 3.72M 3.43M 3.08M 2.87M 2.62M 2.36M 1.56M 1.24M 1.24M 647K
Other Working Capital
452K -1.41M 605K 660K -628K -411K 823K -639K 598K 1.75M -471K -1.9M 217K -1.24M 201K 1.85M -1.93M -60K
Other Non-Cash Items
1.49M -1.06M -1.44M 3.31M -1.57M -1.73M -1.83M 8K 10K -1.13M -888K -444K -33K 33K 14K 30K 22K -150K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a -1.71M -1.4M n/a n/a n/a n/a n/a 26K n/a n/a n/a
Change in Working Capital
994K -1.71M 1.61M 1.68M -1.35M -2.93M -1.99M -400K 3.67M -553K -63K 1.27M 1.82M -1.04M 160K 1.85M -1.93M 1.32M
Operating Cash Flow
-14.44M -16.79M -9.86M -9.55M -11.26M -12.44M -12.8M -14.53M -13.8M -17.42M -15.09M -13.9M -10.5M -11.83M -9.23M -8.16M -8.29M -3.7M
Capital Expenditures
-87K -72K n/a 16K -161K -195K -27K -53K -89K -87K -288K -310K -244K -76K -354K -968K -183K -33K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a -12.07K -19.82K 768.00 63.08K 39K n/a n/a n/a n/a n/a
Purchase of Investments
-39.53M -86.55M -64.37M -66.51M -53.63M -45.66M -74.15M -54.57M -62.37M -33.62M -61.01M -94.01M -157.98M n/a -49.91M -4.32M -26.93M -5.11M
Sales Maturities Of Investments
59.73M 94.49M 66.2M 60.67M 81.13M 66.47M 79.73M 69.89M 74.44M 53.44M 60.24M 30.93M 1.23M 490K 200K 245K 5.54M 28.17M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a 12.07K 19.82K -768 -63.08K 39K 490.00 -49.7K -4.07K -21.39K 23.06K
Investing Cash Flow
20.12M 7.87M 1.83M -5.83M 27.33M 20.62M 5.55M 15.27M 11.98M 19.73M -1.06M -63.39M -156.96M 414K -50.06M -5.04M -21.57M 23.03M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
361K n/a n/a n/a n/a n/a n/a n/a n/a n/a 339K n/a n/a n/a 194K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a 210K n/a 130K 151K -202K 156K 193K 30K 5K n/a
Financial Cash Flow
361K 23K 263K 1K 229K 20K 501K 13K 210.00 n/a 130.00 151.00 -202 156.00 193.00 30.00 5.00 378.98K
Net Cash Flow
6.04M -8.9M -7.76M -15.37M 16.3M 8.2M -6.74M 745K -1.61M 2.31M -16.02M -77.14M -167.66M -11.26M -59.09M -13.18M -29.86M 398.31M
Free Cash Flow
-14.53M -16.86M -9.86M -9.53M -11.42M -12.63M -12.82M -14.59M -13.89M -17.51M -15.38M -14.21M -10.74M -11.9M -9.58M -9.13M -8.47M -3.73M